Arbutus Biopharma Corp. | Key People and Executives
Mark J. Murray
President, Chief Executive Officer & Director
William T. Symonds
Executive Director & Chief Development Officer
Daniel D. Burgess
Independent Director
Herbert J. Conrad
Independent Director
Keith S. Manchester
Independent Director
Richard C. Henriques
Independent Director
Mark J. Murray
President, Chief Executive Officer & Director
David C. Hastings
Chief Financial Officer
Michael J. Sofia
Chief Scientific Officer
James Heyes
Vice President-Drug Delivery
William T. Symonds
Executive Director & Chief Development Officer
Koert VandenEnden
Chief Accounting Officer
Tiffany Tolmie
Manager-Investor Relations
Elizabeth Howard
Executive Vice President & General Counsel
Daniel D. Burgess
Independent Director
Herbert J. Conrad
Independent Director
Keith S. Manchester
Independent Director
Richard C. Henriques
Independent Director
| Address |
8900 Glenlyon Parkway
Burnaby British Columbia V5J 5J8
Canada
|
|
Employees
|
- |
| Website |
http://www.arbutusbio.com |
| Updated |
07/08/2019 |
| Arbutus Biopharma Corp. is a biopharmaceutical company, engages in discovering, developing and commercializing a cure for patients suffering from chronic Hepatitis B virus infection. The company was founded on October 6, 2005 and is headquartered in Burnaby, Canada. . |
